Amgen Inc.

NAS : AMGN
Pharmaceuticals
Thousand Oaks CA
IW Best50N/A
2012 Revenue (US$ Millions)$17,265
2011 Revenue (US$ Millions)$15,582
Revenue Growth (%)10.80%
Net Income (US$ Millions)$4,345
Common Shares Outstanding (Millions)$756
Earnings Per Share (US$)$5.52
Total Equity (US$ Millions)$19,060
Profit Growth (%)17.97
Profit Margin (%)25.17%
Return On Equity (%)22.83%
Long Term Debt (US$ Millions)$24,034
Debt To Equity Ratio (%)1.26%
Market Capitalization (US$ Millions)$65,193
Total Assets (US$ Millions)$54,298
Return on Assets (%)8.89
Current Assets (US$ Millions)$31,209
Inventories (US$ Millions)$2,744
Current Liabilities (US$ Millions)$8,191
Cost of Goods Sold (US$ Millions)$2,918
Asset Turnover0.32
Inventory Turnover1.12